Authors
Loading...
Review reveals how microRNAs modulate antitumor immunity and treatment resistance in cancer, highlighting their promise as immunotherapeutic targets.
Biltekin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: